ArticleReproductive medicine and biology2017

Phase III trial of 8% vaginal progesterone gel for luteal phase support in Japanese women undergoing in vitro fertilization and fresh embryo transfer cycles.

Shoji Kokeguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.